Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.07 USD | -7.59% | +20.35% | -49.76% |
Mar. 27 | Transcript : PAVmed Inc., Q4 2023 Earnings Call, Mar 27, 2024 | |
Mar. 25 | PAVmed Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 107
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Diagnostics, Medical Devices and Digital Health
100.0
%
| 0 | 100.0 % | 2 | 100.0 % | +550.40% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 2 | 100.0 % | +550.40% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lishan Aklog
CEO | Chief Executive Officer | 58 | 14-06-25 |
Dennis McGrath
DFI | Director of Finance/CFO | 67 | 17-03-20 |
Suman M. Verma
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-20 |
Shaun O’Neil
COO | Chief Operating Officer | 42 | 18-07-22 |
Brian deGuzman
CMP | Compliance Officer | 60 | 14-09-30 |
Michael Parks
IRC | Investor Relations Contact | - | - |
Michael Gordon
LAW | General Counsel | 50 | 22-04-30 |
James Mitchell
PRN | Corporate Officer/Principal | - | 21-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Cox
BRD | Director/Board Member | 81 | 14-12-31 |
Ronald Sparks
BRD | Director/Board Member | 69 | 14-12-31 |
Debra White
BRD | Director/Board Member | 62 | 21-04-21 |
Timothy Baxter
BRD | Director/Board Member | 63 | 21-06-09 |
Michael Glennon
BRD | Director/Board Member | 58 | 14-09-30 |
Lishan Aklog
CEO | Chief Executive Officer | 58 | 14-06-25 |
Joan Harvey
BRD | Director/Board Member | 57 | 22-02-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,305,213 | 0 | 0 | 92.97 % |
Stock B | 1 | 9,431,721 | 8,768,263 ( 92.97 %) | 0 |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
LUCID DIAGNOSTICS INC. 64.88% | 31,302,444 | 64.88% | 25,354,980 $ |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.76% | 19.52M | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B | |
+26.14% | 31.88B |
- Stock Market
- Equities
- PAVM Stock
- Company PAVmed Inc.